Wed, April 18, 2012
Tue, April 17, 2012
Mon, April 16, 2012
Sun, April 15, 2012
[ Sun, Apr 15th 2012 ] - Market Wire
DaVita Announces CFO Transition
Sat, April 14, 2012
Fri, April 13, 2012
Thu, April 12, 2012
Wed, April 11, 2012
Tue, April 10, 2012
Mon, April 9, 2012
Fri, April 6, 2012
Thu, April 5, 2012
[ Thu, Apr 05th 2012 ] - Market Wire
April 30, 2012
Wed, April 4, 2012
Tue, April 3, 2012
[ Tue, Apr 03rd 2012 ] - Market Wire
EntreMed Appoints Interim CEO
Mon, April 2, 2012

MannKind to Present at Imperial Capital 2012 Healthcare Investor Forum


//health-fitness.news-articles.net/content/2012/ .. rial-capital-2012-healthcare-investor-forum.html
Published in Health and Fitness on Tuesday, April 10th 2012 at 14:11 GMT by Market Wire   Print publication without navigation


VALENCIA, Calif.--([ ])--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Imperial Capital 2012 Healthcare Investor Forum on Tuesday, April 17, 2012 at 9:00 am Eastern Time at the New York Palace in New York.

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at [ http://www.mannkindcorp.com ].

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its lead product candidate, AFREZZA, is in late stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind maintains a website at [ www.mannkindcorp.com ] to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.


Publication Contributing Sources